Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
- Author:
Hyo Seon RYU
1
;
Hyun Jung KIM
;
Woong Bae JI
;
Byung Chang KIM
;
Ji Hun KIM
;
Sung Kyung MOON
;
Sung Il KANG
;
Han Deok KWAK
;
Eun Sun KIM
;
Chang Hyun KIM
;
Tae Hyung KIM
;
Gyoung Tae NOH
;
Byung-Soo PARK
;
Hyeung-Min PARK
;
Jeong Mo BAE
;
Jung Hoon BAE
;
Ni Eun SEO
;
Chang Hoon SONG
;
Mi Sun AHN
;
Jae Seon EO
;
Young Chul YOON
;
Joon-Kee YOON
;
Kyung Ha LEE
;
Kyung Hee LEE
;
Kil-Yong LEE
;
Myung Su LEE
;
Sung Hak LEE
;
Jong Min LEE
;
Ji Eun LEE
;
Han Hee LEE
;
Myong Hoon IHN
;
Je-Ho JANG
;
Sun Kyung JEON
;
Kum Ju CHAE
;
Jin-Ho CHOI
;
Dae Hee PYO
;
Gi Won HA
;
Kyung Su HAN
;
Young Ki HONG
;
Chang Won HONG
;
Jung-Myun KWAK
;
Author Information
- Publication Type:Guideline
- From:Annals of Coloproctology 2024;40(2):89-113
- CountryRepublic of Korea
- Language:EN
- Abstract: Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.
